OpportunityTitle: Drug Abuse Aspects of HIV/AIDS (R21)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Description: This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), encourages Exploratory/Developmental Research Grant (R21) applications to examine the drug abuse aspects of HIV/AIDS, including research on drug-related risk behaviors, addiction and HIV disease, and drug use/HIV-related co-morbidities and consequences. Applications are needed to identify and predict changes in the epidemiology of HIV/AIDS among injection and non-injection drug users and among their sexual partners; to develop and test interventions for primary and secondary HIV prevention, including drug treatment interventions; to improve HIV testing, counseling, and treatment services for those living with HIV/AIDS; and to address basic mechanisms involved in HIV infection and AIDS pathogenesis in the context of drug abuse and addiction.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;